CY1724A - 3-aryl-oxyazetidinecarboxamides having anti-muscle tension anti-muscle spasticity anticonvulsant and antiepilectic activity - Google Patents

3-aryl-oxyazetidinecarboxamides having anti-muscle tension anti-muscle spasticity anticonvulsant and antiepilectic activity

Info

Publication number
CY1724A
CY1724A CY172494A CY172494A CY1724A CY 1724 A CY1724 A CY 1724A CY 172494 A CY172494 A CY 172494A CY 172494 A CY172494 A CY 172494A CY 1724 A CY1724 A CY 1724A
Authority
CY
Cyprus
Prior art keywords
muscle
oxyazetidinecarboxamides
antiepilectic
anticonvulsant
aryl
Prior art date
Application number
CY172494A
Other languages
English (en)
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of CY1724A publication Critical patent/CY1724A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY172494A 1985-02-28 1994-05-06 3-aryl-oxyazetidinecarboxamides having anti-muscle tension anti-muscle spasticity anticonvulsant and antiepilectic activity CY1724A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70662185A 1985-02-28 1985-02-28
US70663285A 1985-02-28 1985-02-28

Publications (1)

Publication Number Publication Date
CY1724A true CY1724A (en) 1994-05-06

Family

ID=27107712

Family Applications (1)

Application Number Title Priority Date Filing Date
CY172494A CY1724A (en) 1985-02-28 1994-05-06 3-aryl-oxyazetidinecarboxamides having anti-muscle tension anti-muscle spasticity anticonvulsant and antiepilectic activity

Country Status (7)

Country Link
EP (1) EP0194112B1 (fr)
CY (1) CY1724A (fr)
DE (1) DE3671369D1 (fr)
FI (1) FI87559C (fr)
HK (1) HK83893A (fr)
IE (1) IE58943B1 (fr)
SG (1) SG50893G (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5095014A (en) * 1990-12-07 1992-03-10 A. H. Robins Company, Incorporated 3-(2-chloro-4-(trifluoromethyl)phenoxy)-1-azetidine carboxamides having anticonvulsant activity
US5183903A (en) * 1991-11-26 1993-02-02 A. H. Robins Company, Incorporated Urea fusion process for the synthesis of 3-phenoxy-1-azetidinecarboxamides
GB9801501D0 (en) 1998-01-23 1998-03-18 Cerebrus Ltd Chemical compounds - II
EP1049672B1 (fr) * 1998-01-23 2003-09-17 Vernalis Research Limited Derives d'azetidinecarboxamides utilises pour traiter des troubles du systeme nerveux central
DK1049670T3 (da) * 1998-01-23 2002-11-11 Vernalis Res Ltd Azetidincarboxamidderivater til behandling af CNS-lidelser
GB9917385D0 (en) * 1999-07-23 1999-09-22 Cerebrus Ltd Chemical compounds-I
GB9917386D0 (en) * 1999-07-23 1999-09-22 Cerebrus Ltd Chemical compounds-II
WO2011058766A1 (fr) * 2009-11-16 2011-05-19 Raqualia Pharma Inc. Dérivés d'arylcarboxamide comme bloqueurs de ttx-s
JOP20190072A1 (ar) 2016-10-13 2019-04-07 Glaxosmithkline Ip Dev Ltd مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226861A (en) * 1978-04-18 1980-10-07 A. H. Robins Company, Inc. N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides
IL68699A (en) * 1982-08-19 1986-08-31 Robins Co Inc A H 3-phenoxy-1-azetidine-carboxamides,their preparation and pharmaceutical compositions containing them
US4505907A (en) * 1982-09-02 1985-03-19 A. H. Robins Company, Inc. N-Formyl and N-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides

Also Published As

Publication number Publication date
FI860847A (fi) 1986-08-29
SG50893G (en) 1993-07-09
HK83893A (en) 1993-08-20
DE3671369D1 (de) 1990-06-28
EP0194112A1 (fr) 1986-09-10
FI860847A0 (fi) 1986-02-27
FI87559B (fi) 1992-10-15
EP0194112B1 (fr) 1990-05-23
IE58943B1 (en) 1993-12-01
FI87559C (fi) 1993-01-25
IE860522L (en) 1986-08-28

Similar Documents

Publication Publication Date Title
GB2184416B (en) A carrying and discharge assembly
ZA862383B (en) Hydroxamates
GB2161203B (en) Fastening tags
GR860078B (en) Spiro - dioxolanes - dithiolanes and oxothiolanes
GB8624390D0 (en) Slide-type fastener
CY1724A (en) 3-aryl-oxyazetidinecarboxamides having anti-muscle tension anti-muscle spasticity anticonvulsant and antiepilectic activity
GB8420304D0 (en) Module and modular support structure
GB2183244B (en) Olefin-polymerization catalysts and component therefor
EG17807A (en) Antistatic amides
GB2171171B (en) First and second screw-threaded elements
GB8418144D0 (en) Spreader module and assembly
GB8603223D0 (en) Substituted phenylurea
GB8503413D0 (en) Fastening members
GR860549B (en) 3-aryloxyazetidinocarboxamides as anticonvulsants and antiepileptic
GB2172823B (en) Fastening assemblies
GB8509565D0 (en) Fastener assemblies
DE3567239D1 (en) Panelling and carriers therefor
AU4914785A (en) Substituted 1-phenyl-3-benzoyl ureas and thioureas - pesticidal agents
ZA841774B (en) Panelling and carriers therefor
GB2173173B (en) Case and pallet systems
GB8403536D0 (en) Driving aid and mounting
ZA888361B (en) Tension mounting system and assembly
GB8502556D0 (en) Fastening member
GB8429573D0 (en) Active label
IE841533L (en) Isothiazolyl ureas